The Novartis Pharmaceuticals clinical pipeline holds a broad stream of 140 future projects including both new molecular entities and additional indications or formulations for marketed products. Our pipeline has consistently being ranked by experts as one of the strongest in the industry.
Our scientists focus on diseases for which medical need remains unmet and strive to improve the drug discovery process with an approach that integrates novel concepts and tools across multiple disease areas.
Products in development ›
The Novartis Pharmaceuticals clinical pipeline holds a broad stream of about 140 future projects including both new molecular entities and additional indications or formulations for marketed products.
Clinical trials ›
Clinical studies are conducted to ensure the safety and effectiveness of new medicines and vaccines.
Drug discovery and development process ›
Our interactive chart shows the various steps of drug discovery and development, from target selection to registration.
Novartis Institutes for BioMedical Research (NIBR) ›
The Novartis Institutes for BioMedical Research (NIBR) is a global research organization committed to discovering innovative medicines that treat disease and improve human health.
Pharmaceutical Development ›
Novartis Pharmaceutical Development evaluates drug candidates and proves them to be high-quality therapies with superior value to patients.
Novartis Corporate Research ›
The Novartis Corporate Research Institutes foster collaboration and access talent pools throughout the world.
NOVEMBER 14 - WORLD DIABETES DAY
Novartis brings unites with International Diabetes Federation to raise awareness for diabetes.
Our products
We are a leader in offering medicines to protect health, cure disease and improve well-being.
WORLDWIDE offices
Novartis operates in 140 countries around the world.